Has Derek Letort, MD received payments from drug or device companies?

Yes. Drug and device makers reported $25,345 in general payments to Derek Letort, MD across 1,274 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Derek Letort, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Derek Letort, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Derek Letort, MD

Neurology · Jackson, MSNPI 1023202272

Payments from drug & device makers

$25,345in general payments, 2019–2025

Across 1,274 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Pfizer$1K
Teva Pharmaceuticals USA, Inc.$1K
SK Life Science, Inc.$1K
Acadia Pharmaceuticals Inc$1K
UCB, Inc.$1K
plus $17K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	128	$2,198
Pfizer	71	$1,338
Teva Pharmaceuticals USA, Inc.	78	$1,194
SK Life Science, Inc.	51	$1,194
Acadia Pharmaceuticals Inc	60	$1,142
UCB, Inc.	60	$1,130
MDD US Operations, LLC	37	$1,037
Lundbeck LLC	54	$1,036
Biogen	45	$970
Novartis	47	$964
AstraZeneca	37	$893
Neurocrine Biosciences, Inc.	38	$841
Sanofi	39	$808
Lilly USA, LLC	45	$749
Acorda Therapeutics, Inc	29	$632
Argenx US, Inc.	18	$527
Greenwich Biosciences, Inc.	17	$502
Otsuka America Pharmaceutical, Inc.	19	$479
Amgen(2 entities)	25	$468
Biohaven Pharmaceuticals, Inc.	21	$460
Biohaven Pharmaceutical Holding Company Ltd.	23	$459
Merz Pharmaceuticals, LLC	17	$457
Genentech USA, Inc.	25	$399
Impel Pharmaceuticals Inc.	21	$388
Sunovion Pharmaceuticals Inc.	21	$365
Avanir Pharmaceuticals, Inc.	23	$350
Upsher-smith Laboratories LLC	16	$281
EMD Serono, Inc.	26	$273
Catalyst Pharmaceuticals, Inc.	13	$267
Amneal Pharmaceuticals LLC	16	$262
Adamas Pharmaceuticals, Inc.	12	$259
CSL Behring	10	$227
Grifols USA, LLC	7	$225
Sumitomo Pharma America, Inc.	10	$215
Kyowa Kirin, Inc.	9	$201
Jazz Pharmaceuticals Inc.	10	$175
Takeda Pharmaceuticals U.S.A., Inc.	9	$165
GE HealthCare	7	$164
Corium, LLC	10	$148
Neurelis, Inc.	6	$146
Mallinckrodt Hospital Products Inc.	5	$138
Eisai Inc.	4	$112
Axsome Therapeutics, Inc.	4	$89
Insightec,inc	1	$89
Bristol Myers Squibb	5	$80
Sanofi-aventis U.S. LLC	4	$79
Amylyx Pharmaceuticals, Inc.	3	$72
Assertio Therapeutics, Inc.	4	$64
Mallinckrodt Enterprises LLC	3	$62
Medtronic(2 entities)	3	$61
Livanova USA, Inc.	3	$57
ANI Pharmaceuticals, Inc.	3	$56
Johnson & Johnson(2 entities)	3	$56
Supernus Pharmaceuticals, Inc.	4	$48
Alnylam Pharmaceuticals Inc.	2	$42
Abbott	2	$39
Mylan Specialty L.p.	1	$33
Piramal Critical Care	2	$32
Arbor Pharmaceuticals, Inc.	2	$31
Si-bone, Inc.	1	$24

How this compares

$25,345 in reported general payments places this provider in the 75th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$79,521

Medicare patients

612

Services billed

890

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Jackson

Ruth FredericksJackson$943K
Wendell HelvestonJackson$883K
Juebin HuangJackson$231K
Rajesh SharmaJackson$152K
Patrick WeldonJackson$85K
Manasa GunturuJackson$84K
Riichi OtaJackson$53K
Mitchell MyersJackson$43K
Tiffany ScarffJackson$29K
Mark AndersonJackson$28K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →